Cancer Drug's hidden heart risk revealed in small study
NCT ID NCT04813913
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study looked at how bevacizumab (Avastin), a drug used to treat advanced colorectal cancer, affects blood vessels. Researchers measured artery stiffness and blood pressure in 13 patients before and after 4 months of treatment. The goal was to better understand the drug's side effects on the heart and blood vessels, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de ROUEN
Rouen, France
Conditions
Explore the condition pages connected to this study.